カテゴリー： QYResearch, 世界, 医療/バイオ

ヨウ素含有造影剤のグローバル市場2023年：イオヘキソール、イオジキサノール、イオパミドール、イオベルソール、その他

◆英語タイトル：Global Iodine-containing Contrast Medium Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8799）◆商品コード：QYR23MA8799
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：104
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のヨウ素含有造影剤市場について調査・分析し、世界のヨウ素含有造影剤市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（イオヘキソール、イオジキサノール、イオパミドール、イオベルソール、その他）、用途別セグメント分析（病院、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、GE Healthcare、Bayer、Bracco Imaging、Guerbet Group、Hengrui Medicine、Lantheus、Sanochemia、Tyco Healthcare、Imax、Takeda、Fuji Pharma、Towaseiyaku、Hikari Pharmaceutical、Consentis Diagnostics GmbH、T2Pharma、YRPG、BeiLu Pharma、Grupo Juste、Daiichi Sankyoなどが含まれています。世界のヨウ素含有造影剤市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ヨウ素含有造影剤市場規模を推定する際に考慮しました。

・ヨウ素含有造影剤市場の概要
- 製品の定義
- ヨウ素含有造影剤のタイプ別セグメント
- 世界のヨウ素含有造影剤市場規模：タイプ別分析（イオヘキソール、イオジキサノール、イオパミドール、イオベルソール、その他）
- ヨウ素含有造影剤の用途別セグメント
- 世界のヨウ素含有造影剤市場規模：用途別分析（病院、診療所、その他）
- 世界のヨウ素含有造影剤市場規模予測（2018年-2029年）
- ヨウ素含有造影剤の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ヨウ素含有造影剤市場の競争状況およびトレンド

・ヨウ素含有造影剤の地域別市場規模
- 北米のヨウ素含有造影剤市場規模（2018年-2029年）
- アメリカのヨウ素含有造影剤市場規模（2018年-2029年）
- ヨーロッパのヨウ素含有造影剤市場規模（2018年-2029年）
- アジア太平洋のヨウ素含有造影剤市場規模（2018年-2029年）
- 中国のヨウ素含有造影剤市場規模（2018年-2029年）
- 日本のヨウ素含有造影剤市場規模（2018年-2029年）
- 韓国のヨウ素含有造影剤市場規模（2018年-2029年）
- インドのヨウ素含有造影剤市場規模（2018年-2029年）
- オーストラリアのヨウ素含有造影剤市場規模（2018年-2029年）
- 中南米のヨウ素含有造影剤市場規模（2018年-2029年）
- 中東・アフリカのヨウ素含有造影剤市場規模（2018年-2029年）

・タイプ別セグメント：イオヘキソール、イオジキサノール、イオパミドール、イオベルソール、その他
- 世界のヨウ素含有造影剤のタイプ別販売量（2018年-2023年）
- 世界のヨウ素含有造影剤のタイプ別売上（2018年-2023年）
- 世界のヨウ素含有造影剤のタイプ別価格

・用途別セグメント：病院、診療所、その他
- 世界のヨウ素含有造影剤の用途別販売量（2018年-2023年）
- 世界のヨウ素含有造影剤の用途別売上（2018年-2023年）
- 世界のヨウ素含有造影剤の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
GE Healthcare、Bayer、Bracco Imaging、Guerbet Group、Hengrui Medicine、Lantheus、Sanochemia、Tyco Healthcare、Imax、Takeda、Fuji Pharma、Towaseiyaku、Hikari Pharmaceutical、Consentis Diagnostics GmbH、T2Pharma、YRPG、BeiLu Pharma、Grupo Juste、Daiichi Sankyo

・産業チェーンと販売チャネルの分析
- ヨウ素含有造影剤産業チェーン分析
- ヨウ素含有造影剤の主要原材料
- ヨウ素含有造影剤の販売チャネル
- ヨウ素含有造影剤のディストリビューター
- ヨウ素含有造影剤の主要顧客

・ヨウ素含有造影剤市場ダイナミクス
- ヨウ素含有造影剤の業界動向
- ヨウ素含有造影剤市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Iodine-containing Contrast Medium market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Iodine-containing Contrast Medium is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Iodine-containing Contrast Medium is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Iodine-containing Contrast Medium include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, Sanochemia, Tyco Healthcare and Imax, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Iodine-containing Contrast Medium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iodine-containing Contrast Medium.
The Iodine-containing Contrast Medium market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Iodine-containing Contrast Medium market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iodine-containing Contrast Medium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
Sanochemia
Tyco Healthcare
Imax
Takeda
Fuji Pharma
Towaseiyaku
Hikari Pharmaceutical
Consentis Diagnostics GmbH
T2Pharma
YRPG
BeiLu Pharma
Grupo Juste
Daiichi Sankyo
Segment by Type
Iohexol
Iodixanol
Iopamidol
Ioversol
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iodine-containing Contrast Medium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Iodine-containing Contrast Medium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Iodine-containing Contrast Medium Market Overview
1.1 Product Overview and Scope of Iodine-containing Contrast Medium
1.2 Iodine-containing Contrast Medium Segment by Type
1.2.1 Global Iodine-containing Contrast Medium Market Value Comparison by Type (2023-2029)
1.2.2 Iohexol
1.2.3 Iodixanol
1.2.4 Iopamidol
1.2.5 Ioversol
1.2.6 Others
1.3 Iodine-containing Contrast Medium Segment by Application
1.3.1 Global Iodine-containing Contrast Medium Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Iodine-containing Contrast Medium Market Size Estimates and Forecasts
1.4.1 Global Iodine-containing Contrast Medium Revenue 2018-2029
1.4.2 Global Iodine-containing Contrast Medium Sales 2018-2029
1.4.3 Global Iodine-containing Contrast Medium Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Iodine-containing Contrast Medium Market Competition by Manufacturers
2.1 Global Iodine-containing Contrast Medium Sales Market Share by Manufacturers (2018-2023)
2.2 Global Iodine-containing Contrast Medium Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Iodine-containing Contrast Medium Average Price by Manufacturers (2018-2023)
2.4 Global Iodine-containing Contrast Medium Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Iodine-containing Contrast Medium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Iodine-containing Contrast Medium, Product Type & Application
2.7 Iodine-containing Contrast Medium Market Competitive Situation and Trends
2.7.1 Iodine-containing Contrast Medium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Iodine-containing Contrast Medium Players Market Share by Revenue
2.7.3 Global Iodine-containing Contrast Medium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Iodine-containing Contrast Medium Retrospective Market Scenario by Region
3.1 Global Iodine-containing Contrast Medium Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Iodine-containing Contrast Medium Global Iodine-containing Contrast Medium Sales by Region: 2018-2029
3.2.1 Global Iodine-containing Contrast Medium Sales by Region: 2018-2023
3.2.2 Global Iodine-containing Contrast Medium Sales by Region: 2024-2029
3.3 Global Iodine-containing Contrast Medium Global Iodine-containing Contrast Medium Revenue by Region: 2018-2029
3.3.1 Global Iodine-containing Contrast Medium Revenue by Region: 2018-2023
3.3.2 Global Iodine-containing Contrast Medium Revenue by Region: 2024-2029
3.4 North America Iodine-containing Contrast Medium Market Facts & Figures by Country
3.4.1 North America Iodine-containing Contrast Medium Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Iodine-containing Contrast Medium Sales by Country (2018-2029)
3.4.3 North America Iodine-containing Contrast Medium Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Iodine-containing Contrast Medium Market Facts & Figures by Country
3.5.1 Europe Iodine-containing Contrast Medium Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Iodine-containing Contrast Medium Sales by Country (2018-2029)
3.5.3 Europe Iodine-containing Contrast Medium Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Iodine-containing Contrast Medium Market Facts & Figures by Country
3.6.1 Asia Pacific Iodine-containing Contrast Medium Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Iodine-containing Contrast Medium Sales by Country (2018-2029)
3.6.3 Asia Pacific Iodine-containing Contrast Medium Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Iodine-containing Contrast Medium Market Facts & Figures by Country
3.7.1 Latin America Iodine-containing Contrast Medium Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Iodine-containing Contrast Medium Sales by Country (2018-2029)
3.7.3 Latin America Iodine-containing Contrast Medium Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Iodine-containing Contrast Medium Market Facts & Figures by Country
3.8.1 Middle East and Africa Iodine-containing Contrast Medium Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Iodine-containing Contrast Medium Sales by Country (2018-2029)
3.8.3 Middle East and Africa Iodine-containing Contrast Medium Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Iodine-containing Contrast Medium Sales by Type (2018-2029)
4.1.1 Global Iodine-containing Contrast Medium Sales by Type (2018-2023)
4.1.2 Global Iodine-containing Contrast Medium Sales by Type (2024-2029)
4.1.3 Global Iodine-containing Contrast Medium Sales Market Share by Type (2018-2029)
4.2 Global Iodine-containing Contrast Medium Revenue by Type (2018-2029)
4.2.1 Global Iodine-containing Contrast Medium Revenue by Type (2018-2023)
4.2.2 Global Iodine-containing Contrast Medium Revenue by Type (2024-2029)
4.2.3 Global Iodine-containing Contrast Medium Revenue Market Share by Type (2018-2029)
4.3 Global Iodine-containing Contrast Medium Price by Type (2018-2029)
5 Segment by Application
5.1 Global Iodine-containing Contrast Medium Sales by Application (2018-2029)
5.1.1 Global Iodine-containing Contrast Medium Sales by Application (2018-2023)
5.1.2 Global Iodine-containing Contrast Medium Sales by Application (2024-2029)
5.1.3 Global Iodine-containing Contrast Medium Sales Market Share by Application (2018-2029)
5.2 Global Iodine-containing Contrast Medium Revenue by Application (2018-2029)
5.2.1 Global Iodine-containing Contrast Medium Revenue by Application (2018-2023)
5.2.2 Global Iodine-containing Contrast Medium Revenue by Application (2024-2029)
5.2.3 Global Iodine-containing Contrast Medium Revenue Market Share by Application (2018-2029)
5.3 Global Iodine-containing Contrast Medium Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GE Healthcare Iodine-containing Contrast Medium Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Iodine-containing Contrast Medium Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bracco Imaging Iodine-containing Contrast Medium Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Guerbet Group
6.4.1 Guerbet Group Corporation Information
6.4.2 Guerbet Group Description and Business Overview
6.4.3 Guerbet Group Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Guerbet Group Iodine-containing Contrast Medium Product Portfolio
6.4.5 Guerbet Group Recent Developments/Updates
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Corporation Information
6.5.2 Hengrui Medicine Description and Business Overview
6.5.3 Hengrui Medicine Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hengrui Medicine Iodine-containing Contrast Medium Product Portfolio
6.5.5 Hengrui Medicine Recent Developments/Updates
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lantheus Iodine-containing Contrast Medium Product Portfolio
6.6.5 Lantheus Recent Developments/Updates
6.7 Sanochemia
6.6.1 Sanochemia Corporation Information
6.6.2 Sanochemia Description and Business Overview
6.6.3 Sanochemia Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanochemia Iodine-containing Contrast Medium Product Portfolio
6.7.5 Sanochemia Recent Developments/Updates
6.8 Tyco Healthcare
6.8.1 Tyco Healthcare Corporation Information
6.8.2 Tyco Healthcare Description and Business Overview
6.8.3 Tyco Healthcare Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Tyco Healthcare Iodine-containing Contrast Medium Product Portfolio
6.8.5 Tyco Healthcare Recent Developments/Updates
6.9 Imax
6.9.1 Imax Corporation Information
6.9.2 Imax Description and Business Overview
6.9.3 Imax Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Imax Iodine-containing Contrast Medium Product Portfolio
6.9.5 Imax Recent Developments/Updates
6.10 Takeda
6.10.1 Takeda Corporation Information
6.10.2 Takeda Description and Business Overview
6.10.3 Takeda Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Takeda Iodine-containing Contrast Medium Product Portfolio
6.10.5 Takeda Recent Developments/Updates
6.11 Fuji Pharma
6.11.1 Fuji Pharma Corporation Information
6.11.2 Fuji Pharma Iodine-containing Contrast Medium Description and Business Overview
6.11.3 Fuji Pharma Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Fuji Pharma Iodine-containing Contrast Medium Product Portfolio
6.11.5 Fuji Pharma Recent Developments/Updates
6.12 Towaseiyaku
6.12.1 Towaseiyaku Corporation Information
6.12.2 Towaseiyaku Iodine-containing Contrast Medium Description and Business Overview
6.12.3 Towaseiyaku Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Towaseiyaku Iodine-containing Contrast Medium Product Portfolio
6.12.5 Towaseiyaku Recent Developments/Updates
6.13 Hikari Pharmaceutical
6.13.1 Hikari Pharmaceutical Corporation Information
6.13.2 Hikari Pharmaceutical Iodine-containing Contrast Medium Description and Business Overview
6.13.3 Hikari Pharmaceutical Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Hikari Pharmaceutical Iodine-containing Contrast Medium Product Portfolio
6.13.5 Hikari Pharmaceutical Recent Developments/Updates
6.14 Consentis Diagnostics GmbH
6.14.1 Consentis Diagnostics GmbH Corporation Information
6.14.2 Consentis Diagnostics GmbH Iodine-containing Contrast Medium Description and Business Overview
6.14.3 Consentis Diagnostics GmbH Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Consentis Diagnostics GmbH Iodine-containing Contrast Medium Product Portfolio
6.14.5 Consentis Diagnostics GmbH Recent Developments/Updates
6.15 T2Pharma
6.15.1 T2Pharma Corporation Information
6.15.2 T2Pharma Iodine-containing Contrast Medium Description and Business Overview
6.15.3 T2Pharma Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.15.4 T2Pharma Iodine-containing Contrast Medium Product Portfolio
6.15.5 T2Pharma Recent Developments/Updates
6.16 YRPG
6.16.1 YRPG Corporation Information
6.16.2 YRPG Iodine-containing Contrast Medium Description and Business Overview
6.16.3 YRPG Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.16.4 YRPG Iodine-containing Contrast Medium Product Portfolio
6.16.5 YRPG Recent Developments/Updates
6.17 BeiLu Pharma
6.17.1 BeiLu Pharma Corporation Information
6.17.2 BeiLu Pharma Iodine-containing Contrast Medium Description and Business Overview
6.17.3 BeiLu Pharma Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.17.4 BeiLu Pharma Iodine-containing Contrast Medium Product Portfolio
6.17.5 BeiLu Pharma Recent Developments/Updates
6.18 Grupo Juste
6.18.1 Grupo Juste Corporation Information
6.18.2 Grupo Juste Iodine-containing Contrast Medium Description and Business Overview
6.18.3 Grupo Juste Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Grupo Juste Iodine-containing Contrast Medium Product Portfolio
6.18.5 Grupo Juste Recent Developments/Updates
6.19 Daiichi Sankyo
6.19.1 Daiichi Sankyo Corporation Information
6.19.2 Daiichi Sankyo Iodine-containing Contrast Medium Description and Business Overview
6.19.3 Daiichi Sankyo Iodine-containing Contrast Medium Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Daiichi Sankyo Iodine-containing Contrast Medium Product Portfolio
6.19.5 Daiichi Sankyo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Iodine-containing Contrast Medium Industry Chain Analysis
7.2 Iodine-containing Contrast Medium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Iodine-containing Contrast Medium Production Mode & Process
7.4 Iodine-containing Contrast Medium Sales and Marketing
7.4.1 Iodine-containing Contrast Medium Sales Channels
7.4.2 Iodine-containing Contrast Medium Distributors
7.5 Iodine-containing Contrast Medium Customers
8 Iodine-containing Contrast Medium Market Dynamics
8.1 Iodine-containing Contrast Medium Industry Trends
8.2 Iodine-containing Contrast Medium Market Drivers
8.3 Iodine-containing Contrast Medium Market Challenges
8.4 Iodine-containing Contrast Medium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ヨウ素含有造影剤のグローバル市場2023年：イオヘキソール、イオジキサノール、イオパミドール、イオベルソール、その他(Global Iodine-containing Contrast Medium Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ヨウ素造影剤のグローバル市場2023年：イオヘキソール、イオジキサノール、イオパミドール、イオベルソール、イプロミド、その他
  • 世界のヨウ素系造影剤中間体市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆